Michael J. Higgins - 25 Jun 2025 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Reporting relationship: Director
Issuer ticker: CAMP
Reported as of: 25 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Jun 2025, 16:03:01 UTC
Prior SEC filing: 04 Jun 2025
Next SEC filing: 11 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Josh Mandel-Brehm, as Attorney-in-Fact

Key filing fact

Michael J. Higgins filed Form 4 for Camp4 Therapeutics Corp (CAMP) on 27 Jun 2025.

Key facts

This page summarizes Michael J. Higgins's Form 4 filing for Camp4 Therapeutics Corp (CAMP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 Jun 2025, 16:03.

Change

Previous filing in this sequence was filed on 04 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001478521 Primary reporting owner

Higgins Michael J

Relationship: Director
Address: C/O CAMP4 THERAPEUTICS CORPORATION, ONE KENDALL SQ., BLDG 1400 WEST, 3RD FL., CAMBRIDGE
Signature: /s/ Josh Mandel-Brehm, as Attorney-in-Fact
Signature date: 27 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CAMP transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +9,000
Change %
Price: $0.000000
Shares after: 9,000
Date: 25 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,000
Exercise price: $1.56
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service to the issuer's board of directors through the applicable vesting date.